Package leaflet: Information for the patient Vimpat 50 mg film-coated tablets Vimpat 100 mg film-coated tablets Vimpat 150 mg fi
![Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies | SpringerLink Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40263-022-00955-9/MediaObjects/40263_2022_955_Figa_HTML.png)
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies | SpringerLink
![Development of lacosamide for the treatment of partial‐onset seizures - Doty - 2013 - Annals of the New York Academy of Sciences - Wiley Online Library Development of lacosamide for the treatment of partial‐onset seizures - Doty - 2013 - Annals of the New York Academy of Sciences - Wiley Online Library](https://nyaspubs.onlinelibrary.wiley.com/cms/asset/f2b41157-dbf2-42b4-803a-bc00a93b66f5/nyas12213-fig-0001-m.jpg)
Development of lacosamide for the treatment of partial‐onset seizures - Doty - 2013 - Annals of the New York Academy of Sciences - Wiley Online Library
![Lacosamide intake during pregnancy increases the incidence of foetal malformations and symptoms associated with schizophrenia in the offspring of mice | Scientific Reports Lacosamide intake during pregnancy increases the incidence of foetal malformations and symptoms associated with schizophrenia in the offspring of mice | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-64626-9/MediaObjects/41598_2020_64626_Fig1_HTML.png)
Lacosamide intake during pregnancy increases the incidence of foetal malformations and symptoms associated with schizophrenia in the offspring of mice | Scientific Reports
![UCB's VIMPAT® (lacosamide) CV now approved by FDA for primary generalized tonic-clonic seizures and expanded pediatric use for people living with epilepsy UCB's VIMPAT® (lacosamide) CV now approved by FDA for primary generalized tonic-clonic seizures and expanded pediatric use for people living with epilepsy](https://mma.prnewswire.com/media/1336120/Vimpat.jpg?p=facebook)
UCB's VIMPAT® (lacosamide) CV now approved by FDA for primary generalized tonic-clonic seizures and expanded pediatric use for people living with epilepsy
![Cognitive Effects of Lacosamide in Patients with Drug Refractory Focal Epilepsy: A Prospective Observational Study | International Journal of Innovative Research in Medical Science Cognitive Effects of Lacosamide in Patients with Drug Refractory Focal Epilepsy: A Prospective Observational Study | International Journal of Innovative Research in Medical Science](https://ijirms.in/public/journals/1/submission_1309_1388_coverImage_en_US.png)
Cognitive Effects of Lacosamide in Patients with Drug Refractory Focal Epilepsy: A Prospective Observational Study | International Journal of Innovative Research in Medical Science
![The effects of lacosamide on cognitive function and psychiatric profiles in patients with epilepsy - ScienceDirect The effects of lacosamide on cognitive function and psychiatric profiles in patients with epilepsy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525505020307605-gr1.jpg)